Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021
HomeBIOLASEBIOLASE Announces First-Ever U.S. & Canada Regulatory Clearance of Laser Crown and Veneer Removal

BIOLASE Announces First-Ever U.S. & Canada Regulatory Clearance of Laser Crown and Veneer Removal

BIOLASE, Inc. announced that Waterlase dental lasers received U.S. and Canada regulatory clearance for crown and veneer removal. This new indication allows dentists to remove crowns and veneers in less than five minutes using laser technology. BIOLASE is the only dental laser company with this clearance.

Laser crown and veneer removal can offer a more pleasant experience for both the dentist and the patient. This new indication allows dentists to reduce the time it takes to remove crowns and veneers from sometimes 30 minutes to less than five minutes using laser technology. It can also eliminate excess heat by using the natural light of the laser and allows for crowns and veneers to be saved for reuse in some cases.

“This new indication aligns directly with our mission of advancing dentistry,” said BIOLASE CEO, Todd Norbe. “With this clearance, we can now allow patients undergoing crown and veneer removal access to a minimally invasive option that encompasses all of the benefits dental lasers bring to a variety of other procedures, which includes spending less time in the dental chair.”

Please visit Waterlase.com to see other great advancing dentistry indications that are changing the standard of care

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy